Cart
sales@molnova.com
RC-3095 (TFA)
CAS No. 1217463-61-0
RC-3095 (TFA) ( —— )
Catalog No. M22626 CAS No. 1217463-61-0
RC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 732 | In Stock |
|
| 10MG | 1152 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRC-3095 (TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionRC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.
-
DescriptionRC-3095 is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorbombesin/gastrin-releasing peptide (BN/GR)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1217463-61-0
-
Formula Weight1220.34
-
Molecular FormulaC58H80F3N15O11
-
Purity>98% (HPLC)
-
SolubilityH2O:soluble
-
SMILESFC(F)(F)C(=O)O.FC(F)(F)C(=O)O.NC(=O)[C@H](CC(C)C)NC[C@H](CC(C)C)NC(=O)[C@H](Cc1cncn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc3cnc2ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]4Cc5c6ccccc6nc5CN4)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Konturek SJ, et al. Antagonism of receptors for bombesin, gastrin and cholecystokinin in pancreatic secretion and growth. Digestion. 1991;48(2):89-97.
molnova catalog
related products
-
Osthole
Osthole, a potential inhibitor of histamine H1 receptor, has been shown to stimulate osteoblast proliferation and differentiation.
-
Sulfamethoxypyridazi...
Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
-
Praeruptorin B(b)
Praeruptorin B is an inhibitor of sterol regulatory element-binding proteins (SREBPs). It can also significantly up-regulate CYP3A4 expression and activity via the PXR-mediated pathway.
